Susquehanna International Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-217
| Closed | -$8K | – | 14406 |
|
|
2022
Q2 | $8K | Sell |
217
-159
| -42% | -$4.96K | ﹤0.01% | 12554 |
|
|
2022
Q1 | $15K | Sell |
376
-963
| -72% | -$41.3K | ﹤0.01% | 12695 |
|
|
2021
Q4 | $57K | Sell |
1,339
-2,960
| -69% | -$185K | ﹤0.01% | 12482 |
|
|
2021
Q3 | $292K | Sell |
4,299
-3,234
| -43% | -$237K | ﹤0.01% | 10666 |
|
|
2021
Q2 | $580K | Sell |
7,533
-1,261
| -14% | -$76.8K | ﹤0.01% | 9242 |
|
|
2021
Q1 | $579K | Buy |
+8,794
| New | +$685K | ﹤0.01% | 9153 |
|
|
2019
Q4 | – | Sell |
-210
| Closed | -$10K | – | 10871 |
|
|
2019
Q3 | $10K | Sell |
210
-960
| -82% | -$69K | ﹤0.01% | 10020 |
|
|
2019
Q2 | $106K | Sell |
1,170
-820
| -41% | -$99.7K | ﹤0.01% | 9582 |
|
|
2019
Q1 | $294K | Sell |
1,990
-797
| -29% | -$154K | ﹤0.01% | 7250 |
|
|
2018
Q4 | $439K | Sell |
2,787
-3,246
| -54% | -$622K | ﹤0.01% | 6285 |
|
|
2018
Q3 | $1.48M | Buy |
6,033
+5,102
| +548% | +$1.21M | ﹤0.01% | 4510 |
|
|
2018
Q2 | $209K | Buy |
931
+24
| +3% | +$6.43K | ﹤0.01% | 8535 |
|
|
2018
Q1 | $222K | Sell |
907
-409
| -31% | -$107K | ﹤0.01% | 8161 |
|
|
2017
Q4 | $405K | Buy |
1,316
+192
| +17% | +$63.2K | ﹤0.01% | 7031 |
|
|
2017
Q3 | $411K | Sell |
1,124
-37
| -3% | -$13.1K | ﹤0.01% | 6859 |
|
|
2017
Q2 | $423K | Buy |
1,161
+644
| +125% | +$193K | ﹤0.01% | 6948 |
|
|
2017
Q1 | $154K | Sell |
517
-699
| -57% | -$176K | ﹤0.01% | 8181 |
|
|
2016
Q4 | $268K | Buy |
1,216
+900
| +285% | +$180K | ﹤0.01% | 8174 |
|
|
2016
Q3 | $76K | Buy |
316
+75
| +31% | +$15.6K | ﹤0.01% | 8032 |
|
|
2016
Q2 | $47K | Buy |
+241
| New | +$111K | ﹤0.01% | 8256 |
|
|
2014
Q4 | – | Sell |
-227
| Closed | -$74K | – | 10212 |
|
|
2014
Q3 | $74K | Buy |
+227
| New | +$66.6K | ﹤0.01% | 9145 |
|
Other funds holding DMK
Susquehanna International Group's DMK Position: Q1 2024 in Review
Susquehanna International Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 20,237 shares — an estimated $14.2K sold.
Susquehanna International Group first reported a position in DMK in Q2 2014 and held it in 36 quarters. The position peaked at $2.16M in Q3 2018. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.
- Susquehanna International Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
- Susquehanna International Group sold 20,237 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $14.2K.
- Susquehanna International Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2014 and held it in 36 quarters.
- Susquehanna International Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $2.16M in Q3 2018.
- 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.
Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.